Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 27, 2004
Grant Date -
N/A
app pub date -
Oct 16, 2000
filing date -
Oct 6, 1997
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed in part towards methods of modulating the function of serine/threonine protein kinases with 5-azaquinoxaline-based compounds. The methods incorporate cells that express a serine/threonine protein kinase, such as RAF. In addition, the invention describes methods of preventing and treating serine/threonine protein kinase-related abnormal conditions in organisms with a compound identified by the invention. Furthermore, the invention pertains to 5-azaquinoxaline compounds and pharmaceutical compositions comprising these compounds.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully